These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 31468286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma.
    Zhang R, Hardin H, Huang W, Buehler D, Lloyd RV.
    Endocr Pathol; 2018 Mar; 29(1):1-8. PubMed ID: 29280051
    [Abstract] [Full Text] [Related]

  • 3. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV.
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H, Haghpanah V, Irani S, Arefian E, Sohi AN, Fallah P, Soleimani M.
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [Abstract] [Full Text] [Related]

  • 7. Long noncoding RNA landscapes specific to benign and malignant thyroid neoplasms of distinct histological subtypes.
    Yakushina VD, Strelnikov VV, Tanas AS, Lavrov AV.
    Sci Rep; 2021 Aug 18; 11(1):16728. PubMed ID: 34408227
    [Abstract] [Full Text] [Related]

  • 8. FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
    Tsuchida N, Ikeda MA, Ιshino Υ, Grieco M, Vecchio G.
    Int J Oncol; 2017 Jun 18; 50(6):2043-2048. PubMed ID: 28440416
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.
    Cancer; 2005 Jun 01; 103(11):2261-8. PubMed ID: 15880523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A, Jacob RP, Cohen C, Siddiqui MT.
    Diagn Cytopathol; 2016 Jan 01; 44(1):26-31. PubMed ID: 26481593
    [Abstract] [Full Text] [Related]

  • 14. High expression of CD10 in anaplastic thyroid carcinomas.
    Nakazawa T, Kondo T, Vuong HG, Odate T, Kawai M, Tahara I, Kasai K, Inoue T, Oishi N, Mochizuki K, Ito K, Katoh R.
    Histopathology; 2018 Sep 01; 73(3):492-499. PubMed ID: 29791034
    [Abstract] [Full Text] [Related]

  • 15. TROP-2, 5hmC, and IDH1 Expression in Anaplastic Thyroid Carcinoma.
    Seok JY, Astvatsaturyan K, Peralta-Venturina M, Lai J, Fan X.
    Int J Surg Pathol; 2021 Jun 01; 29(4):368-377. PubMed ID: 33289434
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Zhang X, Liu L, Deng X, Li D, Cai H, Ma Y, Jia C, Wu B, Fan Y, Lv Z.
    Oncogene; 2019 Jan 01; 38(5):699-715. PubMed ID: 30171257
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
    Wada N, Yoshida A, Miyagi Y, Yamamoto T, Nakayama H, Suganuma N, Matsuzu K, Masudo K, Hirakawa S, Rino Y, Masuda M, Imada T.
    Anticancer Res; 2008 Jan 01; 28(1A):139-44. PubMed ID: 18383837
    [Abstract] [Full Text] [Related]

  • 19. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM, Huang YW, Huang JS, Wang CH, Kok VC, Hung CM, Chen HM, Tzen CY.
    Ann Surg Oncol; 2007 Oct 01; 14(10):3011-8. PubMed ID: 17638058
    [Abstract] [Full Text] [Related]

  • 20. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM, Di Maro G, Ugolini C, Basolo F, Salvatore G.
    Oncotarget; 2016 Oct 25; 7(43):70575-70588. PubMed ID: 27661106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.